Pretreatment serum C-reactive protein is a significant prognostic factor in patients with soft tissue metastases
Pretreatment serum C-reactive protein is a significant prognostic factor in patients with soft tissue metastases
复制标题
DOI:
10.1016/j.jos.2020.04.017
复制
发表时间:
2021-05-06
影响因子:
1.7
通讯作者:
Tanaka, Sakae
中科院分区:
文献类型:
--
作者:
Ishibashi, Yuki;Kobayashi, Hiroshi;Tanaka, Sakae
Background: Soft tissue metastasis is rarer than bone metastasis. Patients with soft tissue metastasis generally have a dismal prognosis. The treatment for metastatic lesions is sometimes difficult, because the prognostic factors of patients with soft tissue metastasis remain unelucidated. Therefore, this study aimed to identify these prognostic factors.Methods: Thirty-one patients with soft tissue metastasis were included in the study. We evaluated associations of overall survival with clinical parameters and inflammatory markers using Kaplan-Meier curves and Cox proportional hazards models.Results: Twelve patients received surgery for soft tissue metastasis, while radiation therapy was performed in six cases. The median overall survival after the detection of soft tissue metastasis was 11 months. Univariate analysis revealed that detection of soft tissue metastasis after the multidisciplinary treatment (P = 0.01); solitary metastasis (P = 0.0003); and pretreatment C-reactive protein (CRP) level < 0.4 mg/dL (P < 0.0001), white blood cell count < 8500 x 10(3)/mu L (P = 0.0003), and neutrophil-tolymphocyte ratio < 5 (P = 0.02) were significant good prognostic factors. Multivariate analysis revealed that a CRP value < 0.4 mg/dL (P = 0.07) and solitary metastasis (P = 0.09) were possible significant predictors of survival. Furthermore, in case of CRP levels